Figure 1. Development and resolution of proteinuria during sunitinib treatment.
Patient 2 from a published case series (1) had no proteinuria after 1 month of therapy but developed a protein/creatinine ratio of 7.2 (g/g) after 30 weeks of therapy and 10.4 (g/g) after 44 weeks. Proteinuria, hypertension and acute kidney injury completely resolved within 24 weeks of stopping sunitinib.